CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes

Arthritis Research and Therapy

Volumn 8, Issue 2, 2006, Pages

  Zhu, Ping ^a   Lu, Ning ^a   Shi, Zhan Guo ^a   Zhou, Jun ^a   Wu, Zhen Biao ^a   Yang, Yong ^a   Ding, Jin ^a   Chen, Zhi Nan ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PEPTIDE;

ADULT; AGED; BIOSYNTHESIS; CELL CULTURE; COCULTURE; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MIDDLE AGED; MONOCYTE; OSTEOARTHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ANTIGENS, CD147; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME ACTIVATION; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MONOCYTES; OSTEOARTHRITIS; PEPTIDES; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 34247864416     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1899     Document Type: Article

References (39)

1. Yamanishi Y, Firestein GS: PathoTenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 2001, 27 355-371.
2. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
3. Harris ED: Enzymes responsible for joint destruction. In Rheumatoid Arthritis Edited by: Harris ED. Philadelphia, PA: WB Saunders; 1997:168-175.
4. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999, 58:691-697.
5. Toole BP: Emmprin (CD147), a cell surface regulalator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003, 54:371-389.
6. Kasinrerk W, Fiebiger E, Stefanova I, Baumruker T, Knapp W, Stockinger H: Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX- 47, mouse basigin, and chicken HT7 molecule. J Immunol 1992, 149:847-854.
7. Stockinger H, Ebel T, Hansmann C, Koch C, Majdic O, Prager E, Patel DD, Fox A, Horejsi V, Sagawa K, Shen D: Endothelial cell antigens. In Leukocyte Typing VI Edited by: Kishimoto T, Kikutani H, von dem Borne AEGK, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA. New York: Garland Publishing; 1997:760-763.
8. Konttinen YT, Li TF, Mandelin J, Liljestrom M, Sorsa T, Santavirta S, Virtanen I: Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000, 43:275-280.
9. Tomita T, Nakase T, Kaneko M, Shi K, Takahi K, Ochi T, Yoshikawa H: Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 2002, 46:373-378.
10. Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZM: Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: Its potential role in monocytes accumulation and matrix metalloproteinases production. Arthritis Res Ther 2005, 7:R1023-R1033.
11. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in culture human monocytic leukemia cells by phorbol diester. Cancer Res 1982, 42:1530-1536.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
13. Jennings K, Miyamae T, Traister R, Marinov A, Katakura S, Sowders D, Trapnell B, Wilson JM, Gao G, Hirsch R: Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. Mol Ther 2005, 11: 600-607.
14. Lories RJ, Derese I, Ceuppens JL, Luyten FP: Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003, 48:2807-2818.
15. Massova I, Kotra LP, Fridman R, Mobashery S: Matrix metalloproteinases: Structure, evolution, and diversification. FASEB J 1998, 12:1075-1095.
16. Chen Z, Mi L, Xu J, Yu J, Wang X, Jiang J, Xing J, Shang P, Qian A, Yu Li Y, Zhu P, et al.: Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 2005, 191:755-760.
17. Chen ZN, Yang Z, Mi L, Jiang JL, Guo XN: The structural and functional analysis of the hapetoma related factor, HAb18G. Chin J Cell Mol Immunol 1999, 15(1):34-36.
18. Qian AR, Shang P, Luo ZQ, Huang BC, Zahng XD, Chen ZN: A combined bioinformatic approach to analyzing the characteristics of antagonistic peptides against hepatocellular carcinoma marker HAb18G/CD147. J Tumor Marker oncol 2003, 18(1):29-36.
19. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN, Chan HC: The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 2001, 276 46870-46877.
20. Jiang Jian Li, Chan Hsiao Chang, Qing Zhou, Yu Mei Kuen, Yao Xi Ying, Lam Sun Yee, Hu Zhu, Ho Lok Sze, Leung Ka Man, Chen Zhi Nan: HAb18G/ CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains. Cell Mol Life Sci 2004, 61:2083-2091.
21. Chen ZN, Qian AR, Shang P, Huang BC, Li Y, Wang XH, Li HX, Zhu P: Targeting human hepatocellular carcinoma cell membrane antigen HAb18G/ CD147 by its antagonistic peptides. J Tumor Marker oncol 2003, 18(1):5-18.
22. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986, 261:2814-2818.
23. Rusciano D, Welch DR, Burger MM: Cancer metastasis: in vitro and in vivo experimental approaches. The biology of the macrophage In Laboratory Techniques in Biochemistry and Molecular Biology The Macrophage; Elsevier Science Ltd, USA; 2000:101-102.
24. Konttinen YT, Ceponis A, Takagi M, Ainola M, Sorsa T, Sutinen M, Salo T, Ma J, Santavirta S, Seiki M: New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol 1998, 17:585-601.
25. Keyszer G, Redlich A, Haupl T, Zacher J, Sparmann M, Engethum U, Gay S, Burmester GR: Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: A parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum 1998, 41:1378-1387.
26. Cawston T: Matrix metalloproteiPases and TIMPs: properties and implications for the rheumatoid diseases. Mol Med Today 1998, 4:130-137.
27. Maeda S, Sawai T, Uzuki M, Takahashi Y, Omoto H, Seki M, Sakurai M: Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54:970-975.
28. Ishiguro N, Ito T, Miyazaki K, Iwata H: Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycan in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1999, 26:34-40.
29. Ellis SM, Nabeshima K, Biswas C: Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 1989, 49:3385-3391.
30. Muraoka K, Nabeshima K, Murayama T, Biswas C, Koono M: Enhanced expression of a tumor-cell-derived collagenasestimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancers. Int J Cancer 1993, 55:19-26.
31. Polette M, Gilles C, Marchand V, Lorenzato M, Toole B, Tournier JM, Zucker S, Birembaut P: Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1997, 45:703-709.
32. van den Oord JJ, Paemen L, Opdenakker G, de Wolf-Peeters C: Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997, 151:665-670.
33. Koch AE: Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998, 41:951-962.
34. Sun J, Hemler ME: Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001, 61:2276-2281.
35. Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, Li JD, Basbaum C: Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998, 441:88-92.
36. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-439.
37. DeCastro R, Zhang Y, Guo H, Kataoka H, Gordon MK, Toole B, Biswas G: Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol 1996, 106 1260-1265.
38. Marmorstein AD, Bonilha VL, Chiflet S, Neill JM, Rodriguez-Boulan E: The polarity of the plasma membrane protein RET-PE2 in retinal pigment epithelium is developmentally regulated. J Cell Sci 1996, 109:3025-3034.
39. Finneman SC, Marmorstein AD, Neill JM, Rodriguez-Boulan E: Identification of the retinal pigment epithelium protein RETPE2 as CE-9/OX-47, a member of the immunoglobulin superfamily. Invest Ophthalmol Vis Sci 1997, 38:2366-2374.